Benign Prostatic Hyperplasia
Conditions
Interventions
Benign Prostatic Hyperplasia Group:Blue laser vaporization of the prostate is performed to treat benign prostatic hyperplasia (BPH).
Sponsors
The Sixth Medical Center of PLA Hospital
Eligibility
Sex/Gender
Male
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients with moderate to severe lower urinary tract symptoms that significantly affect quality of life may opt for surgical treatment, particularly those who have poor response to or refuse pharmacological therapy. 2. Voluntary informed consent has been signed.
Exclusion criteria
Exclusion criteria: 1. Patients with severe cardiopulmonary dysfunction who are not tolerant of surgery. 2. Patients with coagulation disorders and significant bleeding tendencies (e.g., thrombocytopenic purpura, hemophilia) that cannot be corrected preoperatively to meet surgical requirements. 3. Patients in the acute phase of urinary tract infection, who should undergo surgery only after infection control. 4. Patients with concurrent severe neurological diseases causing bladder dysfunction and inability to cooperate with surgery or postoperative rehabilitation. 5. Suspected or confirmed prostate cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Prostate Symptom Score;Quality of life Score;Maximum flow rate;Post-void residual urine volume;the volume of prostate; | — |
Countries
China
Contacts
Public ContactJia Zhuomin
The Sixth Medical Center of PLA Hospital
Outcome results
None listed